期刊文献+

噻托溴铵治疗支气管扩张合并肺部感染的疗效分析

Efficacy of tiotropium bromide in treatment of bronchiectasis combined with pulmonary infection
在线阅读 下载PDF
导出
摘要 目的:分析噻托溴铵辅助治疗支气管扩张合并肺部感染的临床疗效。方法:将2017年1~12月我院治疗的108例支气管扩张合并肺部感染患者作为研究对象,应用随机数表法分为两组,各54例。对照组接受抗感染、吸氧、气道灌洗等常规对症治疗,观察组加用噻托溴铵治疗。观察两组临床疗效、不良反应及治疗前后肺功能指标、6min步行距离(6MWT)等。结果:与对照组总有效率74.07%相比,观察组总有效率90.74%相对较高,差异有统计学意义(P<0.05);治疗前两组1s用力呼气容积(FEV1)、用力肺活量(FVC)、FEV1占预计值百分比(FEV1%)、6MWT对比,差异无统计学意义(P>0.05);治疗后与对照组FEV1(2.16±0.43)L、FVC(2.79±0.58)L、FEV1%(66.84±11.42)%、6MWT (302.96±40.15)m相比,观察组FEV1(2.79±0.62)L、FVC (3.61±0.74)L、FEV1%(78.92±13.56)%、6MWT(352.01±45.86)m相对较高,差异有统计学意义(P<0.05);两组不良反应发生率7.41%、5.56%相比,差异无统计学意义(P>0.05)。结论:噻托溴铵辅助治疗支气管扩张合并肺部感染安全性较高且疗效确切,利于增强肺功能,提升运动耐力。 Objective:To analyze the clinical efficacy of tiotropium bromide in treatment of bronchiectasis combined with pulmonary infection.Methods:108 patients with bronchiectasis combined with pulmonary infection treated in the hospital from January to December2017 were selected,and they were divided into two groups by random number table,with 54 cases in each group.Control group was given routine treatment with anti-infection,oxygen uptake and tracheal lavage,while observation group was treated with tiotropium bromide.The clinical efficacy,adverse reactions,indexes of pulmonary function,6-minute walking test(6 MWT)in two groups were observed.Results:The total effective rate of observation group(90.74%)was higher than control group(74.07%)(P<0.05);Before treatment,there was no statistical difference in the forced expiratory volume in one second(FEV1),forced vital capacity(FVC),FEV1%,6 MWT between the two groups(P>0.05);After treatment,the FEV1,FVC,FEV1%,6 MWT in observation group[(2.79±0.62)L,(3.61±0.74)L,(78.92±13.56)%,(352.01±45.86)m]were higher than control group[(2.16±0.43)L,(2.79±0.58)L,(66.84±11.42)%,(302.96±40.15)m](P<0.05);There was no statistical statistical difference in the incidence of adverse reactions between the two groups(7.41%VS 5.56%)(P>0.05).Conclusion:Tiotropium bromide in treatment of bronchiectasis combined with pulmonary infection is safe and effective,it can enhance pulmonary function and increase exercise tolerance.
作者 孟庆丽 Meng Qingli(Pharmacy of runan county Traditional Chinese Medicine Hospital in Zhumadian City,Henan Province,463300)
出处 《北方药学》 2019年第4期12-13,共2页 Journal of North Pharmacy
关键词 支气管扩张 肺部感染 噻托溴铵 临床疗效 肺功能 Bronchiectasis Pulmonary infection Tiotropium bromide Clinical efficacy Pulmonary function
  • 相关文献

参考文献11

二级参考文献74

  • 1唐国梁,付强,王雪玲,吴梅华.支气管肺泡灌洗治疗急性重症肺炎15例临床分析[J].中国内镜杂志,2004,10(7):103-103. 被引量:15
  • 2冷蓓峥.肺灌洗治疗支气管扩张并发肺脓肿临床疗效研究[J].湖南中医药大学学报,2011,31(10):57-58. 被引量:9
  • 3陈灏珠.实用内科学(第12版)[M].北京:人民卫生出版社.2008.
  • 4Woodhead M, Blasi F, Ewig S, et al. European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J,2005,26 : 1138-1180.
  • 5Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections - - full version. Clin Microbiol Infect, 2011, 17 Suppl 6: El-E59.
  • 6Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax,2010,65 Suppl 1 :i1- 58.
  • 7Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Am J Respir Cfit Care Med, 2004,169 : A330.
  • 8Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child,2005, 90:737-740.
  • 9Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Clin Pulm M ed,2005,12:205- 209.
  • 10Crofton J. Bronchiectasis. In: Cmflon J, Douglas A, eds. Respiratory diseases. 3 rd eds. Oxford: Blackwell Scientific, 1981:417-430.

共引文献638

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部